Treatment of Parkinsonism with L-dopa and amantadine.
D000547:Amantadine / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos
D010919:Placebos; D004295:Dihydroxyphenylalanine; D000547:Amantadine